Advertisement

HIV-Related Cancer Management in Resource-Limited Settings: A Case Study of Malawi

  • Mina C. Hosseinipour
Chapter

Abstract

The convergence of the AIDS epidemic, HIV-related malignancies and infections, and extreme poverty creates a potentially insurmountable challenge to the overburdened health-care systems of resource-limited countries to provide care to their populations. Yet, given this reality, countries such as Malawi must meet these challenges. In this chapter, we review Malawi’s current approach to the management of HIV-related malignancies, address strategies for continued improvement, and highlight research progress that has been made in the area of Kaposi’s sarcoma management and goals for the future.

Keywords

Cervical Cancer Queen Elizabeth Central Hospital Kamuzu Central Hospital External Referral Malawi College 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. AIDS Clinical Trials Group. (2009 June 2). Available from: https://http://www.actgnetwork.org
  2. Ablashi, D., et al. (1999). Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer 81(5), 893–897.PubMedCrossRefGoogle Scholar
  3. Banda, L. T., et al. (2001). Cancer incidence in Blantyre, Malawi 1994–1998. Trop Med Int Health 6(4), 296–304.PubMedCrossRefGoogle Scholar
  4. Bank, W. (2009) [cited 2009 June 2, 2009]. Available from: http://www.worldbank.org
  5. Barton, M. B., Frommer, M., and Shafiq, J. (2006). Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol 7(7), 584–595.PubMedCrossRefGoogle Scholar
  6. Center for HIV/AIDS Vaccine Immunology. (2009 June 2). Available from: http://www.chavi.org
  7. Chokunonga, E., et al. (2000). Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993–1995. Int J Cancer 85(1), 54–59.PubMedCrossRefGoogle Scholar
  8. Chokunonga, E., et al. (2004). Survival of cervix cancer patients in Harare, Zimbabwe, 1995–1997. Int J Cancer 109(2), 274–277.PubMedCrossRefGoogle Scholar
  9. Dittmer, D. P., and Damania, B. (2007). KSHV-associated disease in the AIDS patient. Cancer Treat Res 133, 129–139.PubMedCrossRefGoogle Scholar
  10. Goldie, S. J., et al. (2005). Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 353(20), 2158–2168.PubMedCrossRefGoogle Scholar
  11. HIV Prevention Trials Network. (2009 June 2). Available from: http://www.hptn.org.
  12. Harries, A. D., Schouten, E. J., and Libamba, E. (2006). Scaling up antiretroviral treatment in resource-poor settings. Lancet 367(9525), 1870–1872.PubMedCrossRefGoogle Scholar
  13. Hosseinipour, M. C., et al. (2006). Lessons learned from a paying antiretroviral therapy service in the public health sector at Kamuzu Central Hospital, Malawi: 1-year experience. J Int Assoc Phys AIDS Care (Chicago, IL 2002) 5(3), 103–108.CrossRefGoogle Scholar
  14. Hosseinipour, M., Abernethy, M., Neuhann, F., Nyirenda, J., and Phiri, S. (2004). Experience with treatment of Kaposi’s sarcoma patients in Lilongwe Malawi. In: 2004 Conference on Retroviruses and Opportunistic Infections, San Francisco, CA.Google Scholar
  15. Hosseinipour, M., Neuhann, F., Kanyama, C., Namarika, D., and Phiri, S. (2004). Mortality is the leading cause of loss to follow-up among antiretroviral patients in Malawi. In: 2004 Conference on Retroviruses and Opportunistic Infections, San Francisco, CA.Google Scholar
  16. Hosseinipour, M., Weigel, R., van Oosterhout, J., Kumwenda, J., Mzinganjira, D., Mhango, B., Phiri, R., and Phiri, S. (2007). Validating clinical and immunological definitions of antiretroviral treatment failure in Malawi. Proceedings of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, Australia.Google Scholar
  17. Hutt, M. R. (1986). Malawi: register of tumour pathology. 1976–1980. In: Parkin, D. M., ed. Cancer Occurrence in Developing Countries, (Lyon, France: IARC Press).Google Scholar
  18. International Collaboration on HIV and Cancer (2000). Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92(22), 1823–1830.CrossRefGoogle Scholar
  19. International Maternal Pediatric Adolescent AIDS Clinical Trials Group. (2009 June 2). Available from: http://www.impaactgroup.org/
  20. Makombe, S. D., et al. (2008). Outcomes of patients with Kaposi’s sarcoma who start antiretroviral therapy under routine programme conditions in Malawi. Trop Doct 38(1), 5–7.PubMedCrossRefGoogle Scholar
  21. Malawi Ministry of Health (2006). Treatment of AIDS: Guidelines for the Use of Antiretroviral Therapy in Malawi, 2nd edn. Anonymous, ed. (Lilongwe, Malawi: Malawi Ministry of Health).Google Scholar
  22. Malawi Ministry of Health (2007). Malawi Reproductive Health Guidelines. R. H. Unit, ed. (Lilongwe, Malawi: Malawi Ministry of Health).Google Scholar
  23. Malawi Ministry of Health (2008). Management of HIV-Related Diseases, 2nd edn. (Lilongwe, Malawi: Ministry of Health).Google Scholar
  24. Malawi Ministry of Health (2009). Department of HIV and AIDS, Ministry of Health 2009, Quarterly Report of the Antiretroviral Treatment Programme in Malawi with Results up to 31 March 2009. Malawi Ministry of Health, Lilongwe, Malawi.Google Scholar
  25. Malawi Ministry of Health (2009). Department of HIV and AIDS, Ministry of Health, Quarterly Report of the Antiretroviral Treatment Programme in Malawi with Results up to 31st December 2008. Malawi Ministry of Health, Lilongwe, Malawi.Google Scholar
  26. Microbicides Trials Network (2009 Jun 2). Available from: http://www.mtnstopshiv.org/
  27. Motti, P. G., et al. (1996). Cervical abnormalities, human papillomavirus, and human immunodeficiency virus infections in women in Malawi. J Infect Dis 173(3), 714–717.PubMedCrossRefGoogle Scholar
  28. Newton, R., et al. (2002). The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer 87(3), 301–308.PubMedCrossRefGoogle Scholar
  29. Parkin, D. M. (2006). The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118(12), 3030–3044.PubMedCrossRefGoogle Scholar
  30. Parkin, D. M., Ferlay, J., Hamdi-Cherif, M., Sitas, F.,Thomas, J. O., Wabinga, H., and Whelan, S. L., eds. (2003). Cancer in Africa: Epidemiology and Prevention. AIDS and Cancer in Africa, Vol. 153 (Lyon, France: IARC Press).Google Scholar
  31. Population and Housing Census Preliminary Report (2008). Population and Housing Census Preliminary Report, N. S. Office, ed. Malawi Government, Zomba, Malawi.Google Scholar
  32. Sankaranarayanan, R., et al. (2009). HPV screening for cervical cancer in rural India. N Engl J Med 360(14), 1385–1394.PubMedCrossRefGoogle Scholar
  33. Schulz, T. F. (1999). Epidemiology of Kaposi’s Sarcoma-associated herpesvirus/human herpesvirus 8. Adv Cancer Res 76, 121–160.PubMedCrossRefGoogle Scholar
  34. Sinfield, R. L., et al. (2007). Spectrum and presentation of pediatric malignancies in the HIV era: experience from Blantyre, Malawi, 1998–2003. Pediatr Blood Cancer 48(5), 515–520.PubMedCrossRefGoogle Scholar
  35. UNAIDS (2008) Report on the Global AIDS Epidemic—Executive Summary. Geneva, Switzerland.Google Scholar
  36. van Oosterhout, J. J. G., Brown, L., Weigel, R., Kumwenda, J. J., Mzinganjira, D., Saukila, N., Mhango, B., Hartung, T., Phiri, S., and Hosseinipour, M. C. (2009). Diagnosing ART failure with immunological and clinical criteria in Malawi. Trop Med Int Health: TM & IH 14(9), 1059–1063.CrossRefGoogle Scholar
  37. Wabinga, H. R., et al. (1993). Cancer in Kampala, Uganda, in 1989–91: changes in incidence in the era of AIDS. Int J Cancer 54(1), 26–36.PubMedCrossRefGoogle Scholar
  38. Wabinga, H. R., et al. (2000). Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997. Br J Cancer 82(9), 1585–1592.PubMedCrossRefGoogle Scholar
  39. Waddell, K. M., et al. (1996). Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol 80(6), 503–508.PubMedCrossRefGoogle Scholar
  40. World Health Organization. (2006). Antiretroviral Therapy for HIV infection in adults and adolescents in Resource-Limited Settings: Toward Universal Access. Recommendations for a public health approach, ed. Anonymous. World Health Organization, Geneva, Switzerland.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Division of Infectious DiseasesUniversity of North CarolinaChapel HillUSA

Personalised recommendations